Every SEC Form 3/4/5 on record for this filer (CIK 1604019) — 5 issuers, 149 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| XLO | Xilio Therapeutics, Inc. | Director | 2021-10-21 → 2026-06-12 | 6 | — |
| INSM | INSMED Inc | Chief Financial Officer | 2020-02-05 → 2026-06-05 | 34 | −$44M |
| SCPH | scPharmaceuticals Inc. | Director | 2020-07-13 → 2025-10-07 | 8 | — |
| ONCS | ONCOSEC MEDICAL Inc | CFO/COO · lapsed | 2018-07-18 → 2020-01-21 | 9 | −$5,043 |
| ADXS | Advaxis, Inc. | Chief Financial Officer · lapsed | 2015-07-01 → 2018-04-03 | 39 | −$194,567 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| INSM | 2026-06-03 | Sell | 2,404 | $102.27 | $245,857 | 69,082 |
| INSM | 2026-05-13 | Sell | 8,272 | $116.18 | $961,041 | 71,486 |
| INSM | 2026-02-03 | Sell | 748 | $156.34 | $116,942 | 79,758 |
| INSM | 2026-01-08 | Sell | 1,447 | $174.17 | $252,024 | 80,506 |
| INSM | 2026-01-07 | Sell | 1,678 | $175.07 | $293,767 | 81,953 |
| INSM | 2026-01-06 | Sell | 1,517 | $173.33 | $262,942 | 83,631 |
| INSM | 2025-07-21 | Sell | 26,310 | $103.03 | $3M | 73,505 |
| INSM | 2025-07-21 | Sell | 32,090 | $102.38 | $3M | 99,815 |
2 of 5 issuers are covered and open a security page; the rest are on file here only.
